Best Developed ex-US ETF EU 2026: World ex-US UCITS
Compare top UCITS Developed Markets ex-US ETFs in 2026: TER, AUM, Japan and Europe weights, EU tax treatment, plus a 100k EUR portfolio tilt worked example.
Best Developed Markets ex-US ETF for EU Investors in 2026 Deep Dive
The "Developed ex-US" exposure is the quietest important ETF category of the 2020s. It barely existed for European retail before 2022. Now it's growing rapidly because the same problem keeps recurring: standard MSCI World is roughly 70% US, and a meaningful share of EU investors no longer want that concentration without choosing it deliberately.
The thesis is straightforward. If you believe US equities are richly valued, structurally over-concentrated in big tech, or simply want to express a de-dollarisation view without going to cash or EM, "World ex-US" is the surgical tool. You keep developed-market quality (governance, liquidity, currency stability) but redirect the weight to Japan, Western Europe, Canada, Australia, and developed Asia.
This deep dive compares the best UCITS developed-markets ex-US ETFs in 2026, breaks down country composition (Japan, UK, France, Switzerland, Germany, Canada, Australia, Netherlands), walks through EU tax treatment across DE/FR/IT/ES/PL, and ends with a 100k EUR portfolio tilt example.
TL;DR
- Top UCITS pick: iShares MSCI World ex USA UCITS ETF (Acc) — ticker IQQE / IWXS, ISIN IE000QPKM254, TER 0.20%, AUM around 1.1 billion EUR, accumulating.
- Runner-up: Xtrackers MSCI World ex USA UCITS ETF 1C — ISIN LU2089238302 (or related), TER 0.20%, smaller AUM.
- Use case: core-to-tilt allocation of 10 to 30% of an equity portfolio, paired with a sized US allocation (or zero US) to deliberately control US weight. Also useful for investors who already hold a US-specific ETF and want to round out the global picture.
Developed ex-US Market Overview
MSCI World ex USA covers 22 developed-market countries. As of early 2026, country weights are approximately:
- Japan: ~22%
- United Kingdom: ~14%
- France: ~10%
- Switzerland: ~9%
- Canada: ~9%
- Germany: ~8%
- Australia: ~6%
- Netherlands: ~4%
- Denmark: ~3%
- Sweden: ~3%
- Italy: ~3%
- Spain: ~2%
- Hong Kong: ~2%
- Singapore, Finland, Belgium, Norway, Ireland, Israel, NZ, Austria, Portugal: ~5% combined
This block excludes the US (~70% of MSCI World) and excludes emerging markets. Sector mix differs materially from MSCI World:
- Financials: 19% (vs 14% in MSCI World — banks/insurers carry more weight)
- Industrials: 16% (vs 11%)
- Healthcare: 13% (vs 11% — Roche, Novo Nordisk, Novartis)
- Consumer Discretionary: 11% (vs 10% — Toyota, LVMH)
- Consumer Staples: 8% (vs 7%)
- IT: 8% (vs 25% — far less tech-heavy)
- Materials: 6%, Communication 5%, Energy 5%, Utilities 5%, Real Estate 2%
The IT underweight is the headline difference. MSCI World gets 25% tech weight from US mega-caps; MSCI World ex USA has SAP, ASML, Sony, Keyence, Tokyo Electron — meaningful but at 8% it's a different portfolio profile.
Combined nominal GDP across the block: ~38 trillion USD. Population: ~1.0 billion.
Top UCITS Developed Markets ex-US ETFs Compared
The category is smaller than EM ex-China. iShares is the largest player; Xtrackers and Amundi provide alternatives. Several products use "MSCI World ex USA" or "FTSE Developed ex North America" benchmarks with slightly different scope.
1. iShares MSCI World ex USA UCITS ETF (Acc) — IQQE / IWXS
- ISIN: IE000QPKM254
- Issuer: iShares
- TER: 0.20%
- AUM: around 1.1 billion EUR
- Replication: physical (sampled)
- Distribution: accumulating
- Listings: Xetra (IWXS / IQQE), London, Amsterdam, Borsa Italiana, SIX
- Holdings: ~870 stocks across 22 developed markets
The reference product. Largest AUM, accumulating, broad coverage.
2. Xtrackers MSCI World ex USA UCITS ETF 1C
- ISIN: IE000UQND7H4 (Xtrackers UCITS share class issued in 2023)
- Issuer: DWS
- TER: 0.15%
- AUM: around 600 million EUR
- Replication: physical (sampled)
- Distribution: accumulating
Cheapest TER in the category at 0.15%. Newer product, AUM growing.
3. Amundi MSCI World ex USA II UCITS ETF
- ISIN: LU2670264894 (typical Amundi share class)
- Issuer: Amundi
- TER: 0.15% to 0.18%
- AUM: around 400 million EUR
- Replication: physical
- Distribution: accumulating
Solid Amundi alternative, similar TER, useful where broker fee schedules favour Amundi.
4. SPDR MSCI World ex USA UCITS ETF
- ISIN: IE00BYTRRD19
- Issuer: State Street (SPDR)
- TER: 0.20%
- AUM: around 250 million EUR
- Replication: physical
- Distribution: accumulating
SPDR product, slightly smaller AUM. Standard MSCI World ex USA exposure.
5. iShares MSCI EAFE / iShares Core MSCI EAFE UCITS
- "EAFE" (Europe, Australasia, Far East) is a closely related index — MSCI World ex USA ex Canada. UCITS coverage of pure EAFE is limited; most EU investors use MSCI World ex USA instead which includes Canada (9% of the index).
- For investors who specifically want EAFE (no Canada), Canada-specific ETFs paired with European/Asia coverage are an alternative.
6. Vanguard FTSE Developed Europe + Vanguard FTSE Developed Asia Pacific ex Japan + dedicated Japan ETF combo
- For investors who want to build their own ex-US block, combining regional Vanguard products (FTSE Developed Europe ex UK + FTSE Developed Asia Pacific + Japan) can achieve roughly similar coverage at very low aggregate TER. Operational complexity is higher; rebalancing is on you.
Holdings Breakdown
MSCI World ex USA top 10 (early 2026, approximate weights):
| # | Stock | Country | Sector | Weight |
|---|---|---|---|---|
| 1 | Novo Nordisk | Denmark | Healthcare | 2.4% |
| 2 | ASML | Netherlands | IT | 2.2% |
| 3 | Toyota Motor | Japan | Consumer Disc. | 2.0% |
| 4 | Nestlé | Switzerland | Cons. Staples | 1.9% |
| 5 | LVMH | France | Consumer Disc. | 1.7% |
| 6 | Roche | Switzerland | Healthcare | 1.6% |
| 7 | Shell | UK | Energy | 1.5% |
| 8 | Novartis | Switzerland | Healthcare | 1.5% |
| 9 | SAP | Germany | IT | 1.4% |
| 10 | HSBC Holdings | UK | Financials | 1.3% |
Top 10 = ~17% of the index. Notably less concentrated than MSCI World (where Apple + Microsoft + Nvidia alone can exceed 17%).
Market cap split: large 75%, mid 23%, small 2% (this is large/mid; the IMI version with small caps has tighter UCITS coverage).
Risk Angles
Currency. Multi-currency basket — JPY, GBP, EUR, CHF, CAD, AUD. Net FX impact against EUR varies; CHF has been a tailwind, JPY a meaningful headwind in 2022 to 2024. No EUR-hedged Developed ex-US UCITS product has reached scale yet.
Concentration risk lower than World. Top 10 = 17% vs MSCI World top 10 around 22%. Sector mix more balanced. This is the structural feature that draws investors.
Japan-specific risks. Japan is 22% of the index. JPY volatility, governance reform progress, and demographic compounding all affect this allocation more than they affect MSCI World (where Japan is 5%). Detail in the Japan deep dive on this site.
UK political risk. UK is 14% of the index. Brexit aftermath, political volatility, and sterling moves are recurring factors but generally manageable.
Sector tilt risks. With IT at 8% (vs 25% in World), this ETF will underperform when US mega-cap tech leads global returns. The flip side: it outperforms when value/financials/industrials lead, as happened in 2022 to early 2024.
No regulatory risk premium. All constituent countries are MSCI-classified developed markets. Lowest aggregate political risk available outside US-only or pure-Europe exposure.
Performance Comparison
Trailing 5-year EUR returns to early 2026:
| Index | Annualised Return |
|---|---|
| MSCI World ex USA | approx. 8.5% |
| MSCI World | approx. 11.4% |
| MSCI USA | approx. 13.0% |
| MSCI Europe | approx. 9.0% |
| MSCI Japan | approx. 9.1% |
MSCI World ex USA has underperformed MSCI World by ~3 percentage points annualised over this 5-year window — driven entirely by US mega-cap dominance. Over 15+ year windows the gap is smaller. Over the 2000 to 2010 "lost decade" for US equities, MSCI World ex USA actually outperformed.
Correlation of MSCI World ex USA to MSCI World (10-year monthly): ~0.92. High, because both share the same global cycle. But correlation to MSCI USA alone is ~0.83 — meaningful diversification against single-country US risk.
Tax Treatment Across the EU
Germany. Teilfreistellung 30% applies. Effective CGT ~18.46%. Vorabpauschale on accumulating share classes.
France. Not PEA-eligible (PEA is EU/EEA only; World ex-US contains UK, Switzerland, Japan, Canada, Australia, etc., outside EU/EEA). CTO at 30% PFU, or assurance-vie.
Italy. 26% flat CGT on realisation.
Spain. 19% to 28% progressive CGT.
Poland. Belka 19% on realisation. Accumulating shielded annually. IKE/IKZE compatible — well-suited for long-horizon wrapper accumulation.
When a Developed ex-US Tilt Makes Sense
- You believe US is over-concentrated. MSCI USA at 21x forward earnings vs MSCI World ex USA at ~13.5x. Mean-reversion thesis.
- You're building a custom global allocation. Splitting World into US + ex-US gives you direct control over your US weight (which is otherwise dictated by index weighting).
- You hold a separate US tech ETF. Adding World ex-US fills out the rest of developed markets without doubling up on US.
- De-dollarisation thesis. USD as a long-term reserve faces structural challenges; ex-US exposure reduces USD dependency.
- Sector diversification. Less IT, more financials/industrials/healthcare. Different return drivers.
When It Doesn't
- You're happy with market-cap weighting. Then VWCE / IWDA are simpler and cheaper.
- You believe US continues to dominate. Then overweight US, not ex-US.
- Short horizon. Recent 5-year underperformance versus World has been severe. If sequence-of-returns matters, this is the wrong vehicle.
- You can't tolerate Japan + UK + Switzerland combined being 45% of your sleeve. This is what you're buying.
Broker Availability
| Broker | Available products | Notes |
|---|---|---|
| Trade Republic | iShares MSCI World ex USA, Xtrackers, Amundi | Savings plans available |
| Scalable Capital | Full UCITS World ex USA universe | Free savings plans |
| DEGIRO | Major UCITS products, often on core selection | Commission-free on some |
| Interactive Brokers | Full universe | Best execution for large tickets |
| mBank Brokers (https://www.mbank.pl) | iShares IWXS via Xetra | Polish desktop |
| BOSSA (https://bossa.pl) | iShares MSCI World ex USA via foreign markets | IKE/IKZE compatible |
For Polish investors with IKE/IKZE shelter, https://bossa.pl or https://www.mbank.pl typically lists iShares IWXS as the practical default. Trade Republic and IBKR offer Xtrackers MSCI World ex USA at the lowest TER (0.15%). Revolut (https://revolut.com/referral/?referral-code=rafa9jcta!MAR1-26-AR) has limited UCITS ex-US product coverage in 2026; US-listed VEU / IXUS are not UCITS and unsuitable for typical EU tax-residency structures.
Worked Example: 100k EUR + 20% World ex-US Tilt over 20 Years
Portfolio A: 100% VWCE (market-cap global). 7% real EUR → 387k EUR after 20 years.
Portfolio B: 80% VWCE + 20% iShares World ex USA. The mechanical effect: increase ex-US weight from ~30% (inside VWCE) to ~46%, decrease US weight from ~63% to ~50%, EM from ~10% to ~8%.
Scenario 1 (mean-reversion plays out): World ex USA delivers 8.5% annualised real EUR vs 7% for VWCE. Blended portfolio: ~7.30% → ~414k EUR. ~27k EUR ahead.
Scenario 2 (US continues to dominate): World ex USA delivers 5.5% annualised real EUR. Blended portfolio: ~6.70% → ~366k EUR. ~21k EUR behind.
The dispersion is wider than other tilts because you're taking a structural view on US vs rest-of-world. Many investors split the difference: 10% rather than 20% tilt, gives controllable exposure without betting the portfolio on a single regime call.
A 20-year Financial Freedom Runway (FFR) view sharpens this: 27k EUR ahead is roughly 12 to 18 months of additional runway on a typical Polish FI budget. 21k EUR behind is the same period lost. Tilts have option-like payoff profiles, and the right framing is how many months of life they buy or cost — not just CAGR deltas. Freenance models exactly this trade-off per scenario.
Polish Reader Angle
For Polish investors, iShares IWXS (MSCI World ex USA) is the standard for IKE/IKZE wrapper holding via https://bossa.pl or https://www.mbank.pl. Xtrackers MSCI World ex USA at 0.15% TER is the cost-optimised choice on Trade Republic, IBKR, or Scalable Capital outside the wrapper.
Belka 19% applies on realisation outside IKE/IKZE. Accumulating share class avoids annual tax events.
Currency triangulation is the cleanest of the country-tilt categories: PLN → EUR funding → developed-market currency basket (JPY, GBP, CHF, CAD, AUD, EUR). Aggregate FX volatility is lower than EM or India tilts. CHF has been a structural EUR tailwind over decades; JPY has been a headwind recently but neutral-to-positive longer-term.
FAQ
Q: Is World ex USA the same as EAFE? A: Close but not identical. EAFE = Europe, Australasia, Far East — excludes Canada. World ex USA includes Canada (9% of the index). For most retail investors, the World ex USA version is the right default because Canada is included.
Q: Should I pair World ex USA with a US-specific ETF? A: That's the design pattern. e.g. 50% Core S&P 500 (CSPX / VUAA) + 50% World ex USA gives you a controllable US-vs-rest-of-world allocation. Compare to 100% VWCE which dictates ~63% US.
Q: Is the Xtrackers product better than iShares? A: Xtrackers TER 0.15% vs iShares 0.20% — Xtrackers is cheaper. iShares has larger AUM and tighter spreads. For long-horizon buy-and-hold, Xtrackers wins on cost; for active rebalancing, iShares wins on execution.
Q: Is World ex USA PEA-eligible? A: No. PEA requires EU/EEA exposure; this ETF holds UK, Swiss, Japanese, Canadian, Australian equities outside EU/EEA.
Q: What about IMI version with small caps? A: MSCI World ex USA IMI UCITS coverage is limited in 2026. Most retail uses the large/mid cap standard version. Small-cap sleeve can be added separately via a dedicated EAFE small cap or MSCI World ex USA Small Cap product where available.
Q: How does this differ from MSCI ACWI ex US? A: ACWI ex US includes emerging markets. World ex USA excludes them. If you want EM included with the ex-US block, ACWI ex US is the answer (UCITS coverage limited; iShares MSCI ACWI ex US UCITS exists with smaller AUM).
Sources
- MSCI index methodology (MSCI World ex USA, MSCI World ex USA IMI, MSCI EAFE, MSCI ACWI ex USA)
- FTSE Russell (FTSE Developed ex North America) methodology
- iShares, Xtrackers, Amundi, SPDR official factsheets and KIID documents
- BIS and IMF data on global equity market capitalisation 2025 to 2026
- National tax authority guidance (BMF Germany, Agenzia delle Entrate Italy, AEAT Spain, KIS Poland, DGFiP France)
Disclaimer
This article is educational and does not constitute investment advice under Polish or EU regulations. Past performance is not a reliable indicator of future returns. Developed Markets ex-US exposure carries market, currency, sector-concentration, and regulatory risks across multiple jurisdictions. Tax rules vary by jurisdiction and individual circumstances; consult a licensed advisor before acting. Freenance does not provide personalised investment advice and is not authorised by KNF or any other competent authority as an investment firm.
Want full control over your finances?
Try Freenance for free